Australian Type 2 Diabetes Risk (AUSDRISK) Assessment Tool
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–5
- Intermediate Risk6–8
- Intermediate Risk9–11
- High Risk12–15
The Australian Type 2 Diabetes Risk (AUSDRISK) Assessment Tool calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include age. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates 5-year risk of developing type 2 diabetes in Australian patients based on demographic, lifestyle and simple anthropometric measures
Clinical Indication
The Australian Type 2 Diabetes Risk (AUSDRISK) Assessment Tool is indicated for bedside clinical practice to support Estimates 5-year risk of developing type 2 diabetes in Australian patients based on demographic, lifestyle and simple anthropometric measures. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management. Guideline pearl: The tool has 74% sensitivity and 67.7% specificity at the ≥12 point threshold..
Score = Age points + Sex points + Ethnicity points + Parental diabetes points + High blood glucose history points + Antihypertensive medication points + Smoking points + Physical inactivity points + Waist circumference points
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | string | Yes | Age group of the patient |
| sex | string | Yes | Biological sex of the patient |
| ethnicity | string | Yes | Ethnic background of the patient |
| parental_diabetes | string | Yes | Family history of diabetes in parents |
| high_blood_glucose_history | string | Yes | History of high blood glucose levels (e.g., during pregnancy, illness, or health check) |
| antihypertensive_medication | string | Yes | Currently taking medication for high blood pressure |
| current_smoker | string | Yes | Currently smoking cigarettes or other tobacco products on a daily basis |
| physical_activity | string | Yes | Physical activity status - Active if ≥150 minutes/week of walking (continuous ≥10 min) or moderate/vigorous activity |
| waist_circumference_category | string | Yes | Waist circumference category based on ethnicity and sex-specific cut-points |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–5 | Low Risk | 5 or less points |
| 6–8 | Intermediate Risk | 6-8 points |
| 9–11 | Intermediate Risk | 9-11 points |
| 12–15 | High Risk | 12-15 points |
| 16–19 | High Risk | 16-19 points |
| 20–35 | Very High Risk | 20 or more points |
Evidence-Based References (EBM)
- Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, et al. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust. 2010;192(4):197-202.